Skip to main content
    S

    Sight Sciences Inc (SGHT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $10.59
    -0.24 (-2.22%)

    Market Cap: $601.92M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Sight Sciences Inc (SGHT) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Sight Sciences are Rxsight (RXST), Tactile Systems Technology (TCMD) and Senseonics Holdings, Inc. Common Stock (SENS). By market cap, Sight Sciences ranks 6th of the 13 companies on this page; Integra LifeSciences Holdings (IART) is the largest at $1.12B. The median P/E of the 5 companies with a P/E is 23.7x.

    Peer Comparison

    SGHT's ROIC of -29.0% is below the peer median of -18.0%, and its revenue growth of 25.2% is above the median of 10.8%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Sight Sciences (SGHT)$601.92MN/A6.6x-32.1%-29.0%25.2%0.00%
    Rxsight Inc (RXST)$223.06MN/A1.8x-43.8%-23.3%-19.0%0.00%
    Tactile Systems Technology Inc (TCMD)$600.58M23.7x1.7x6.7%N/A7.1%0.00%
    Senseonics Holdings, Inc. Common Stock (SENS)$579.58MN/A11.9x-204.2%-71.4%141.6%0.00%
    Integra LifeSciences Holdings (IART)$1.12B5.5x0.7x0.8%2.1%2.3%0.00%
    Avita Medical Ltd (RCEL)$491.10MN/A5.5x-42.6%-159.3%53.1%0.00%
    Si-Bone Inc (SIBN)$1.06BN/A4.8x-6.2%-6.0%14.5%0.00%
    QuidelOrtho Corp (QDEL)$736.90M11.9x0.3x-14.2%-2.9%-11.6%0.00%
    Delcath Systems Inc (DCTH)$714.89M124.2x6.5x6.0%N/A70.7%0.00%
    Brainsway Ltd (BWAY)$406.96M27.8x3.4x15.6%N/A35.4%0.00%
    Beta Bionics, Inc. Common Stock (BBNX)$892.71MN/A5.6x-65.3%-18.0%30.3%0.00%
    Standard Biotools Inc (LAB)$279.27MN/A3.8x157.6%-9.9%-0.9%0.00%
    Treace Medical Concepts Inc (TMCI)$345.50MN/A1.4x-27.4%-32.8%-3.9%0.00%
    Peer median$590.08M23.7x3.6x-10.2%-18.0%10.8%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Sight Sciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Devices.

    CompanyAboutPeers
    Rxsight Inc (RXST)
    Rxsight Inc. is a cutting-edge healthcare technology company dedicated to transforming vision correction through advanced diagnostic and surgical solutions...
    RXST competitors
    Tactile Systems Technology Inc (TCMD)
    Tactile Systems Technology, Inc., a medical technology company, is dedicated to the development and supply of medical devices for chronic diseases in the United...
    TCMD competitors
    Senseonics Holdings, Inc. Common Stock (SENS)
    Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United...
    SENS competitors
    Integra LifeSciences Holdings (IART)
    Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery...
    IART competitors
    Avita Medical Ltd (RCEL)
    AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom.
    RCEL competitors
    Si-Bone Inc (SIBN)
    SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States...
    SIBN competitors
    QuidelOrtho Corp (QDEL)
    Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health...
    QDEL competitors
    Delcath Systems Inc (DCTH)
    Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
    DCTH competitors
    Brainsway Ltd (BWAY)
    Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel...
    BWAY competitors
    Beta Bionics, Inc. Common Stock (BBNX)
    Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development...
    BBNX competitors
    Standard Biotools Inc (LAB)
    Standard Biotools Inc. (LAB) is a pioneering biotechnology company dedicated to enhancing genomic analysis and biological research through cutting-edge tools...
    LAB competitors
    Treace Medical Concepts Inc (TMCI)
    Treace Medical Concepts, Inc., an orthopedic medical device company, is dedicated to the design, manufacture...
    TMCI competitors

    Frequently Asked Questions About SGHT

    Who are Sight Sciences' main competitors?

    The companies most similar to Sight Sciences include Rxsight (RXST), Tactile Systems Technology (TCMD), Senseonics Holdings, Inc. Common Stock (SENS), Integra LifeSciences Holdings (IART) and Avita Medical (RCEL), listed from the closest match.

    Who is Sight Sciences' biggest competitor?

    Integra LifeSciences Holdings (IART) is the largest of the similar companies at $1.12B; Rxsight (RXST) is the closest match by business profile, size, sector and industry.

    How does SGHT stock compare with its competitors?

    SGHT's P/S is 6.6x against a peer median of 3.6x; its net margin is -32.1% against a peer median of -10.2%.

    Which of Sight Sciences' competitors pays a higher dividend?

    Sight Sciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Sight Sciences bigger than its competitors?

    No. Sight Sciences is 6th by market cap among the 13 companies on this page; the largest is Integra LifeSciences Holdings (IART) at $1.12B.